William L. Macias
Chief Tech/Sci/R&D Officer presso IMMUNOVANT, INC.
Patrimonio netto: 12 M $ in data 31/03/2024
Profilo
William L.
Macias is currently the Senior Medical Director at Lilly Research Laboratories, Director at Immunetrics, Inc., and Chief Medical Officer at Immunovant, Inc. He was previously the Chief Executive Officer at Focus Biomedical Consulting LLC from 2018 to 2021, Chief Medical Officer at PROMETHERA Biosciences SA from 2019 to 2020, and an Associate Professor at The Indiana University School of Medicine.
Macias received his undergraduate degree from Marquette University and his doctorate from The Indiana University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
IMMUNOVANT INC
0.26% | 17/04/2024 | 377 650 ( 0.26% ) | 12 M $ | 31/03/2024 |
Posizioni attive di William L. Macias
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNOVANT, INC. | Chief Tech/Sci/R&D Officer | 01/06/2021 |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Corporate Officer/Principal | - |
Immunetrics, Inc.
 Immunetrics, Inc. BiotechnologyHealth Technology Immunetrics, Inc. operates as a bio-simulation company. The company was founded by Carson Chow, Timothy R. Billiar, Gilles Clermont, Mitchell P. Fink and Yoram Vodovotz in 2001 and is headquartered in Pittsburgh, PA. | Director/Board Member | - |
Precedenti posizioni note di William L. Macias
| Società | Posizione | Fine |
|---|---|---|
| Focus Biomedical Consulting LLC | Chief Executive Officer | 01/05/2021 |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Chief Tech/Sci/R&D Officer | 01/01/2020 |
| The Indiana University School of Medicine | Corporate Officer/Principal | - |
Formazione di William L. Macias
| Marquette University | Undergraduate Degree |
| The Indiana University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| IMMUNOVANT, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
Immunetrics, Inc.
Immunetrics, Inc. BiotechnologyHealth Technology Immunetrics, Inc. operates as a bio-simulation company. The company was founded by Carson Chow, Timothy R. Billiar, Gilles Clermont, Mitchell P. Fink and Yoram Vodovotz in 2001 and is headquartered in Pittsburgh, PA. | Health Technology |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Health Technology |
| Focus Biomedical Consulting LLC |
- Borsa valori
- Insiders
- William L. Macias
